HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

I Cervinková Selected Research

Inflammation (Inflammations)

4/2012[Interleukin-1 receptor blockade with anakinra provided cessation of fatigue, reduction in inflammation markers and regression of retroperitoneal fibrosis in a patient with Erdheim-Chester disease - case study and a review of literature].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


I Cervinková Research Topics

Disease

1Castleman Disease (Castleman's Disease)
04/2013
1Chronic Disease (Chronic Diseases)
04/2013
1Fatigue
04/2012
1Inflammation (Inflammations)
04/2012
1Retroperitoneal Fibrosis
04/2012
1Erdheim-Chester Disease
04/2012
1Amyloidosis
03/2012

Drug/Important Bio-Agent (IBA)

1Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2013
1Proteins (Proteins, Gene)FDA Link
04/2013
1Dexamethasone (Maxidex)FDA LinkGeneric
04/2013
1Thalidomide (Thalomid)FDA Link
04/2013
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
04/2012
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
04/2012
1Amyloid (Amyloid Fibrils)IBA
03/2012

Therapy/Procedure

1Injections
04/2012
1Therapeutics
04/2012